compounded semaglutide glendale Flex-Dose 1 mL Injectable 2.5 mg/mL Compounded Semaglutide With B6 (Pyridoxine)

Patients should be advised to contact their GP or NHS 111 if they experience: Red flag symptoms requiring urgent assessment: Severe, persistent abdominal pain , particularly if in the upper abdomen and radiating to the back (may indicate pancreatitis) Severe abdominal pain and distension with vomiting and inability to pass wind or stools (may indicate bowel obstruction) Persistent vomiting , particularly if unable to keep down fluids, raising concerns about dehydration Abdominal distension with rigidity or extreme tenderness on palpation Blood in vomit or stools (melaena or haematochezia) Unintentional weight loss beyond expected therapeutic effects Fever accompanying abdominal symptoms , which may suggest infection or inflammation Right upper quadrant pain or jaundice (yellowing of skin/eyes), which may indicate gallbladder disease For severe symptoms, call 999 or go to A&E immediately

Dosages can be increased every 30 days until the maximum dose is reached

Even if the FDA greenlights sales of peptides in accordance with the advisory panels votes, the peptides in question will not have FDA approval as a drug

: